Evidence Exchange - New York City, New York 10001

Evidence Exchange is categorized under in New York City, NY .

Business Name: Evidence Exchange
Contact Person: Myron Eagle
Address: 21 Penn Plaza, New York City, New York 10001
Phone Number: (212) 594-2500
Website Address: evidenceexchange.com
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2003
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 6722
NAICS Code: 525910
Share This Business:
Related Businesses: Seawinds Asset Management LLC - New York City, NY 10001
Cosmed Inc - New York City, NY 10001
Global Capital Resources Group LLC - New York City, NY 10001
Pioneer Fund Inc - New York City, NY 10001
Hallmark Investment Series Trust - New York City, NY 10001
Hallmark Equity Series Trust - New York City, NY 10001
Reserve Short-Term Investment Trust - New York City, NY 10001
Reserve Tax-Exempt Trust - New York City, NY 10001
Reserve New York Tax-Exempt Trust - New York City, NY 10001
Flat World Capital LLC - New York City, NY 10001
The Reserve Fund Inc - New York City, NY 10001
Reserve Yield Plus Fund - New York City, NY 10001
Dje Wealth Management Inc - New York City, NY 10001
The Steamfitters Industry Security Benefit Fund - New York City, NY 10001
Tavros Capital Partners - New York City, NY 10001
Gardner Webster Capital Partners - New York City, NY 10001

The company Evidence Exchange provides BOTH services in the form of from its single location in New York. 1 to 4 employees work for Evidence Exchange, and the business now earns $100.000 to $499.999 per annum.

Evidence Exchange was launched in 2003 and is classified under SIC code and category 6722 , and NAICS number and grouping 525910 . To contact Evidence Exchange, please call Myron Eagle with the phone number (212) 594-2500 or visit its single location at 21 Penn Plaza in New York City, New York 10001.

The location of the single location can also be found using the coordinates 40.752586,-73.993378. Read more details about this business on the webpage evidenceexchange.com or follow the company’s social media accounts, on Twitter and on Facebook.